The How: Current Predictors of Response to Immune Checkpoint Inhibitors

Download this slideset to review expert guidance on the optimal application of PD-L1 testing to predict response to checkpoint inhibitor–based therapy in lung cancer.
person default
Sanjay Mukhopadhyay, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 4.41 MB
Released: September 11, 2019


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by educational grants from
Bristol-Myers Squibb
Merck Sharp & Dohme Corp

Related Content

In this slideset, Sandip P. Patel, MD, reviews emerging predictors of response to checkpoint inhibitors in lung cancer.

Sandip P. Patel, MD Released: September 11, 2019

In this slideset, H. Jack West, MD, reviews the latest clinical data supporting the optimal use of checkpoint inhibitor therapy across lung cancer.

H. Jack West, MD Released: September 10, 2019

Caron A. Jacobson, MD: Latest data and clinical potential for using CAR T-cells plus checkpoint inhibitors to overcome CAR T-cell–resistant DLBCL

person default Caron A. Jacobson, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: September 10, 2019 Expiration: September 9, 2020

From Clinical Care Options, download slides reviewing the integration of CAR T-cell therapy into community care.

person default Michael R. Bishop, MD Jae H. Park, MD Released: September 6, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?